These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 17964089)

  • 21. The Mycoplasma hyopneumoniae recombinant heat shock protein P42 induces an immune response in pigs under field conditions.
    Jorge S; de Oliveira NR; Marchioro SB; Fisch A; Gomes CK; Hartleben CP; Conceição FR; Dellagostin OA
    Comp Immunol Microbiol Infect Dis; 2014 Sep; 37(4):229-36. PubMed ID: 25082621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral vaccination of piglets against Mycoplasma hyopneumoniae using silica SBA-15 as an adjuvant effectively reduced consolidation lung lesions at slaughter.
    Mechler-Dreibi ML; Almeida HMS; Sonalio K; Martines MAC; Petri FAM; Zambotti BB; Ferreira MM; Storino GY; Martins TS; Montassier HJ; Sant'Anna OA; Fantini MCA; de Oliveira LG
    Sci Rep; 2021 Nov; 11(1):22377. PubMed ID: 34789792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Performance parameters and pathogen detection in pig groups differently vaccinated with respect to Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae].
    Tameling A; Könighoff P; Beilage EG; Menrath A; Heimann M; Köhrmann A; Hennig-Pauka I
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2022 Feb; 50(1):21-29. PubMed ID: 35235980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
    Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
    BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Field trial on the simultaneous vaccination against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae].
    Herbich E; Heissenberger B; Ladinig A; Griessler A; Ritzmann M; Weissenbacher-Lang C; Hennig-Pauka I
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2013; 41(5):279-88. PubMed ID: 24126996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal vaccination strategy against Mycoplasma hyopneumoniae, porcine reproductive and respiratory syndrome virus, and porcine circovirus type 2 in case of early M. hyopneumoniae infection.
    Yang S; Oh T; Mago J; Iwakuma A; Chae C
    Vet Med Sci; 2020 Nov; 6(4):860-874. PubMed ID: 32462794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.
    Martelli P; Saleri R; Cavalli V; De Angelis E; Ferrari L; Benetti M; Ferrarini G; Merialdi G; Borghetti P
    Vet Microbiol; 2014 Jan; 168(2-4):357-64. PubMed ID: 24332702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acclimation strategies in gilts to control Mycoplasma hyopneumoniae infection.
    Garza-Moreno L; Segalés J; Pieters M; Romagosa A; Sibila M
    Vet Microbiol; 2018 Jun; 219():23-29. PubMed ID: 29778201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial treatment of Mycoplasma hyopneumoniae infections.
    Maes D; Boyen F; Haesebrouck F; Gautier-Bouchardon AV
    Vet J; 2020; 259-260():105474. PubMed ID: 32553237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different local, innate and adaptive immune responses are induced by two commercial
    Beuckelaere L; Haspeslagh M; Biebaut E; Boyen F; Haesebrouck F; Krejci R; Meyer E; Gleerup D; De Spiegelaere W; Devriendt B; Maes D
    Front Immunol; 2022; 13():1015525. PubMed ID: 36569943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2.
    Kim D; Kim CH; Han K; Seo HW; Oh Y; Park C; Kang I; Chae C
    Vaccine; 2011 Apr; 29(17):3206-12. PubMed ID: 21354247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
    Jeong J; Park C; Choi K; Chae C
    Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus,
    Jeong J; Kang I; Kim S; Park KH; Park C; Chae C
    Can J Vet Res; 2018 Jan; 82(1):39-47. PubMed ID: 29382967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of combined vaccination against Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus in dually infected pigs.
    Bourry O; Fablet C; Simon G; Marois-Créhan C
    Vet Microbiol; 2015 Nov; 180(3-4):230-6. PubMed ID: 26422712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.
    Michiels A; Arsenakis I; Boyen F; Krejci R; Haesebrouck F; Maes D
    BMC Vet Res; 2017 Aug; 13(1):274. PubMed ID: 28851359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence and risk factors associated with seropositivity in sows from 67 herds in north-west Germany infected with Mycoplasma hyopneumoniae.
    Grosse Beilage E; Rohde N; Krieter J
    Prev Vet Med; 2009 Apr; 88(4):255-63. PubMed ID: 19101052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of diet source and vaccination for porcine circovirustype 2 and Mycoplasma hyopneumoniae on nursery pig performance.
    Potter ML; Kane EM; Bergstrom JR; Dritz SS; Tokach MD; Derouchey JM; Goodband RD; Nelssen JL
    J Anim Sci; 2012 Nov; 90(11):4063-71. PubMed ID: 22665636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefit-cost analysis to estimate the payback time and the economic value of two Mycoplasma hyopneumoniae elimination methods in breeding herds.
    Silva GS; Yeske P; Morrison RB; Linhares DCL
    Prev Vet Med; 2019 Jul; 168():95-102. PubMed ID: 31097130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Mycoplasma hyopneumoniae vaccine on pigs naturally infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome virus.
    Moreau IA; Miller GY; Bahnson PB
    Vaccine; 2004 Jun; 22(17-18):2328-33. PubMed ID: 15149792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune responses elicited by Mycoplasma hyopneumoniae recombinant antigens and DNA constructs with potential for use in vaccination against porcine enzootic pneumonia.
    Virginio VG; Gonchoroski T; Paes JA; Schuck DC; Zaha A; Ferreira HB
    Vaccine; 2014 Oct; 32(44):5832-8. PubMed ID: 25148775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.